{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:28:39Z","timestamp":1648549719226},"reference-count":37,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1179\/joc.2005.17.5.521","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T18:05:43Z","timestamp":1389290743000},"page":"521-526","source":"Crossref","is-referenced-by-count":1,"title":["Key Pharmacokinetic Parameters of Isepamicin in Febrile Neutropenic Cancer Patients and in Women with Acute Pelvic Inflammatory Disease"],"prefix":"10.1080","volume":"17","author":[{"given":"J.C.","family":"Yombi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Wallemacq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Gala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Vandercam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"issue":"1","key":"CIT0001","first-page":"403","volume":"1","author":"Hare RS","year":"1980","journal-title":"Curr Chemother Infect Dis"},{"key":"CIT0002","first-page":"S7\u2013S16","volume":"7","author":"Jones RN. Isepamicin","year":"1995","journal-title":"J Chemother"},{"key":"CIT0003","first-page":"S17\u2013S30","volume":"7","author":"Miller GH","year":"1995","journal-title":"The most fre-quently occurring aminoglycoside resistance mechanisms: combined results of surveys in eight regions of the world. J Chemother"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.10.2201"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/AAC.41.8.1794","volume":"41","author":"Radwanski E","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.11.2382"},{"key":"CIT0007","first-page":"606","volume":"31","author":"Uematsu T","year":"1993","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1128\/AAC.40.4.983","volume":"40","author":"Tod M","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.5.702"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0002-9378(81)90954-6","volume":"139","author":"Zaske DE","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/clinchem\/37.8.1415","volume":"37","author":"Leal T","year":"1991","journal-title":"Clin Chem"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1007\/BF01086153"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/106002809302700319","volume":"27","author":"Watling SM","year":"1993","journal-title":"Ann Pharmacother"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199705000-00016"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198804000-00004"},{"key":"CIT0016","unstructured":"Tod M, Minozzi K, Louchahi J, Cougnard J, Petitjean O. Population pharmacokinetics study of isepamicin in febrile neutropenic patients. [Abstract A 23] 36th Interscience Conference of Antimicrobial Agents and Chemotherapy 1996, Sept 15-18, New Orleans."},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200038030-00002"},{"key":"CIT0018","first-page":"299","volume":"44","author":"Pivot-Dumarest C","year":"1996","journal-title":"Path Biol"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.8.1406"},{"key":"CIT0020","first-page":"626","volume":"5","author":"Manny RP","year":"1986","journal-title":"Clin Pharm"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(96)00054-3"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/132.3.270"},{"key":"CIT0023","first-page":"25","volume-title":"Nephrology. 1st ed.","author":"Baylis C","year":"1997"},{"key":"CIT0024","volume-title":"Aminoglycosides. In:","author":"Zaske D.E","year":"1992"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(01)80073-1"},{"key":"CIT0026","first-page":"703","volume-title":"Temperature regulation and the patho-genesis of fever. In:","author":"Mackowiak PA","year":"2005","edition":"6"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.22.2.193"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.1.93"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/149.3.443"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90358-9"},{"key":"CIT0032","first-page":"623","volume":"12","author":"Destache CJ","year":"1990","journal-title":"Ther Drug Monit"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.1.320"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.40.5.1108","volume":"40","author":"Cometta A","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/AAC.42.7.1842","volume":"42","author":"Kashuba ADM","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D337"},{"key":"CIT0037","doi-asserted-by":"crossref","unstructured":"Schentag JJ, Gilliland KK, Paladino JA. What have we learned from pharmacokinetic and pharmacodynamic theo-ries? Clin Infect Dis 2001; 32 (suppl 1): S39-46.","DOI":"10.1086\/319375"},{"key":"CIT0038","volume-title":"Why do neutrophils markedly reduce the 24-hr AUC\/MIC required for efficacy of fluoro-quinolones against Streptococcus pneumoniae. (abstract 9-492). In:","author":"Kiem S","year":"2002"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T21:49:33Z","timestamp":1597355373000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.2005.17.5.521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1179\/joc.2005.17.5.521"],"URL":"https:\/\/doi.org\/10.1179\/joc.2005.17.5.521","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}